{"id":"W2795058050","doi":"10.1200/jco.2017.76.3656","title":"Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bendamustine; Obinutuzumab; Internal medicine; Rituximab; Gastroenterology; Neutropenia; Hazard ratio; Refractory (planetary science); Follicular lymphoma; Surgery; Lymphoma; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003065265,0.0002880695,0.001807509,0.0002542466,0.00007024407,0.00002353466,0.0002245232,0.000339281,0.00003489896],"category_scores_gemma":[0.001017351,0.000160899,0.0001714709,0.0002809205,0.0003115944,0.0002111119,0.0000869161,0.0007018562,0.000007906086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002858765,"about_ca_system_score_gemma":0.002134153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001053214,"about_ca_topic_score_gemma":0.002864201,"domain_scores_codex":[0.9956365,0.0006749699,0.002200617,0.0004091835,0.0006789349,0.000399788],"domain_scores_gemma":[0.996117,0.001299479,0.001435198,0.0003365485,0.0005707156,0.0002410391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02262426,0.01206371,0.8622687,0.00001768522,0.000272268,0.0007539204,0.001986708,0.00002604036,0.000002340916,0.00002518493,0.0005317396,0.09942744],"study_design_scores_gemma":[0.1016921,0.04831238,0.8460622,0.0003339426,0.0002186158,0.0001037005,0.0008628407,0.00009834193,0.00000495417,0.00009015392,0.002083809,0.0001369875],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965008,0.0001143264,0.000007213148,0.0009701055,0.0009553581,0.0009593908,0.000005960482,0.000005876568,0.000480984],"genre_scores_gemma":[0.9972869,0.0003505436,0.0003934976,0.001050146,0.0008142011,0.00002828356,0.000006422578,0.00002344519,0.00004653759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09929045,"threshold_uncertainty_score":0.7475572,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05563711913773614,"score_gpt":0.380538862532708,"score_spread":0.3249017433949719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}